Cargando…
Burden of disease associated with a COPD eosinophilic phenotype
PURPOSE: Based on blood and sputum samples, up to 40% of patients with COPD have eosinophilic inflammation; however, there is little epidemiology data characterizing the health care burden within this sub-population. Given that COPD-attributable medical costs in the USA are predicted to approach $50...
Autores principales: | Ortega, Hector, Llanos, Jean-Pierre, Lafeuille, Marie-Hélène, Germain, Guillaume, Duh, Mei Sheng, Bell, Christopher F, Sama, Susan R, Hahn, Beth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097826/ https://www.ncbi.nlm.nih.gov/pubmed/30147308 http://dx.doi.org/10.2147/COPD.S170995 |
Ejemplares similares
-
Health characteristics of patients with asthma, COPD and asthma–COPD overlap in the NHANES database
por: Llanos, Jean-Pierre, et al.
Publicado: (2018) -
Real-world characteristics and disease burden of patients with asthma prior to treatment initiation with mepolizumab or omalizumab: a retrospective cohort database study
por: Llanos, Jean-Pierre, et al.
Publicado: (2019) -
Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities
por: Kalhan, Ravi, et al.
Publicado: (2021) -
Clinical burden of illness among patients with severe eosinophilic COPD
por: Müllerová, Hana, et al.
Publicado: (2019) -
Upper airway symptoms associate with the eosinophilic phenotype of COPD
por: Obling, Nicolai, et al.
Publicado: (2021)